BNP Paribas Asset Management
TBIO

BNP Paribas Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

BNP Paribas Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,000
Closed -$413K – 934
2021
Q2 		$413K Hold
15,000
– – ﹤0.01% 828
2021
Q1 		$247K Hold
15,000
– – ﹤0.01% 826
2020
Q4 		$276K Buy
+15,000
New +$268K ﹤0.01% 812

BNP Paribas Asset Management's TBIO Position: Q3 2021 in Review

BNP Paribas Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 15,000 shares — an estimated $413K sold.

BNP Paribas Asset Management first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $413K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • BNP Paribas Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • BNP Paribas Asset Management sold 15,000 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $413K.
  • BNP Paribas Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • BNP Paribas Asset Management's Translate Bio, Inc. Common Stock position peaked at $413K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on BNP Paribas Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.